在克罗恩病的背景下,爱斯坦-巴尔病毒结肠炎
Zane Attard1, Matthias Barbara2, Elizier Zahra Bianco3
1Medicine, Mater Dei Hospital, Msida, Malta zaneattard@outlook.com.
BMJ case reports
|January 9, 2026
概括
这项案例研究突出显示了爱斯坦-巴尔病毒 (EBV) 在患有炎症性肠病 (IBD) 的患者中的重新激活. 监测EBV病毒载量对于有效管理耐火性IBD病例至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 的管理可能是复杂的,特别是在耐火性症状的情况下.
- 爱斯坦-巴尔病毒 (EBV) 再激活是免疫受损患者,包括IBD患者的新兴问题.
研究的目的:
- 提出一种可能与EBV重新激活相关的耐火性IBD病例.
- 探索EBV病毒载量监测在指导复杂IBD病例治疗决策中的作用.
主要方法:
- 一份病例报告详细介绍了一个中年女性,有IBD病史.
- 结肠镜与PCR测试在炎症组织中检测EBVDNA.
- 治疗调整包括类固醇,阿扎西奥普林,因弗利克西马布和维多利祖马布.
- 治疗药物监测用于infliximab.
主要成果:
- 在炎症的结肠组织中检测到EBV DNA水平升高 (6961副本/毫升).
- 最初的免疫抑制提供了部分缓解,但由于不良影响,阿扎西奥普林的治疗被停止.
- 尽管EBVDNA下降,但因弗利克西马布治疗失败,需要切换到维多利祖马布.
- 维多利祖马布在这种耐火性IBD患者中表现出良好的临床反应.
结论:
- 在耐火性IBD患者中,常规EBV病毒载量监测可能有益.
- 在IBD中治疗EBV相关性结肠炎需要仔细考虑免疫抑制策略.
- 这一案例凸显了复杂IBD病例与病毒共感染的挑战和潜在的治疗途径.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
945
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
945
Chronic Bowel Disorders: Introduction
743
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Gastritis-II: Pathophysiology
1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K


